Cellectar Biosciences (NV40.MU) Q2 2026 Earnings

14MayConfirmed
Q2 2026
-1.62
-1.46
-1.3
-1.14

Details

Expected EPS
-1.6160105
Actual EPS
-1.140209
Surprise EPS
0.48
Surprise Percent
+29.44%

Description

Cellectar Biosciences (NV40.MU) has reported earnings of -1.140209 per share for Q2 2026.

0 Comments

Share your thoughts